Counterpart to Registration Rights Agreement December 22, 2014

EX-10.210 6 ex10210rracounterpart53752.htm RRA 5.375% 2023 DEC 22 Ex. 10.210 RRA Counterpart 5.375% 2023
Exhibit 10.210

Counterpart to Registration Rights Agreement
December 22, 2014
Each of the undersigned hereby absolutely, unconditionally and irrevocably agrees as a Guarantor, as defined in the Registration Rights Agreement, dated June 30, 2014 by and among Endo Finance LLC, a Delaware limited liability company and Endo Finco Inc., a Delaware corporation, the Guarantors party thereto, Citigroup Global Markets Inc. and RBC Capital Markets, relating to the 5.375% Senior Notes due 2023, to be bound by the terms and provisions of such Registration Rights Agreement.

1

Exhibit 10.210

IN WITNESS WHEREOF, each of the undersigned has executed this counterpart as of the date first written above.

BOCA PHARMACAL, LLC, as a
    by GENERICS INTERNATIONAL (US), INC., its
     sole member
By:
/s/ Deanna Voss
 
Name: Deanna Voss 
 
Title: Assistant Secretary

DAVA INTERNATIONAL, LLC, as a
    by DAVA PHARMACEUTICALS, INC., its
     sole member
By:
/s/ Deanna Voss
 
Name: Deanna Voss 
 
Title: Assistant Secretary

DAVA CAPITAL MANAGEMENT, INC., as a
By:
/s/ Deanna Voss
 
Name: Deanna Voss 
 
Title: Assistant Secretary

2